Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Paul Hession is a personal expert-services website based in Neuchâtel, Switzerland. It positions itself as a GCP-certified provider of scientific editing, technical writing, and clinical trial registration support. It is not a standard SaaS or enterprise software product; rather, it is closer to a professional outsourcing service for research authors, biotech companies, and clinical trial sponsors. Its core goal is to help clients improve the accuracy and compliance of journal publications, regulatory submissions, and clinical trial disclosures.
The website presents three main service areas: academic manuscript editing, regulatory document writing/editing, and ClinicalTrials.gov registration support. For manuscripts, it emphasizes logical structure, native-level English, and adherence to journal styles such as AMA, APA, and Chicago. For regulatory work, it covers CSRs, investigator brochures, and IRB submission materials, with an emphasis on familiarity with FDA, EMA, and GCP templates. For clinical trial registration, it offers ClinicalTrials.gov data entry, MeSH term handling, QA review-comment responses, and support for meeting FDAAA 801 and ICMJE requirements.
Pricing is project-based. The site only provides a Request a Quote option and states that it will respond within 24 hours after a project summary is submitted. It does not disclose fixed packages, hourly rates, delivery timelines, or service levels. For organizations with defined procurement budgets, upfront communication will still be needed to confirm scope, deliverables, and confidentiality terms.
From a SaaS perspective, the site does not show any account system, online workspace, team permissions, approval workflows, third-party integrations, APIs, or cloud/self-hosted deployment options. As such, it is not suitable as a replacement for an internal enterprise document management or clinical operations system. Its security and compliance information is mainly reflected in strict confidentiality, the ability to sign an NDA, and the provider’s ICH-GCP certification and experience with relevant regulatory guidelines.
Its strengths are its strong professional focus, coverage of high-barrier scenarios such as medical writing, scientific publication, and clinical trial disclosure, plus 20 years of technical writing experience and more than 10 years of scientific editing/registration experience. The drawbacks are that the service depends on an individual expert, with limited scalability, limited pricing transparency, and little in the way of software-based capabilities. It is best suited to researchers and small to mid-sized biotech teams that need high-quality English medical writing, regulatory document polishing, or ClinicalTrials.gov registration support.
Access from mainland China cannot be determined from the site content, and payment methods are not disclosed. If local communication, RMB payment, or China-compliant delivery is required, alternatives to compare include Editage, Enago, AJE, Cactus, LetPub, as well as domestic medical writing and clinical registration consulting services.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on paulhession.com official site.
paulhession.com is an Ireland SaaS provider. TG4G tracks its product information, an overall rating of 5.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach paulhession.com directly.